231 related articles for article (PubMed ID: 26705956)
1. Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes.
Lewis GD; Holliday EB; Kocak-Uzel E; Hernandez M; Garden AS; Rosenthal DI; Frank SJ
Head Neck; 2016 Apr; 38 Suppl 1():E1886-95. PubMed ID: 26705956
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
[TBL] [Abstract][Full Text] [Related]
3.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
4. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
[TBL] [Abstract][Full Text] [Related]
5. Helical tomotherapy of nasopharyngeal carcinoma-any advantages over conventional intensity-modulated radiotherapy?
Wu WC; Mui WL; Fung WK
Med Dosim; 2010; 35(2):122-7. PubMed ID: 19931024
[TBL] [Abstract][Full Text] [Related]
6. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
[TBL] [Abstract][Full Text] [Related]
7. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Li X; Kitpanit S; Lee A; Mah D; Sine K; Sherman EJ; Dunn LA; Michel LS; Fetten J; Zakeri K; Yu Y; Chen L; Kang JJ; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Lee NY
JAMA Netw Open; 2021 Jun; 4(6):e2113205. PubMed ID: 34143193
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) for the treatment of head and neck cancer: A dosimetric comparison.
Nguyen ML; Cantrell JN; Ahmad S; Henson C
Med Dosim; 2021 Autumn; 46(3):259-263. PubMed ID: 33648823
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy for nasopharyngeal carcinoma using simultaneously integrated boost (SIB) protocol: a comparison planning study between intensity modulated arc radiotherapy vs. intensity modulated radiotherapy.
Liu T; Chen J; Gong G; Zhang G; Bai T; Sun T; Lu J; Ma C; Yin Y
Technol Cancer Res Treat; 2012 Oct; 11(5):415-20. PubMed ID: 22568626
[TBL] [Abstract][Full Text] [Related]
11. Segment edit and segment weight optimization: two techniques for intensity modulated radiation therapy and their application to the planning for nasopharyngeal carcinoma.
Li Q; Pei H; Mu J; Hu Q; Gu W
Technol Cancer Res Treat; 2013 Oct; 12(5):403-9. PubMed ID: 23617287
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
[TBL] [Abstract][Full Text] [Related]
13. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy.
Takiar V; Ma D; Garden AS; Li J; Rosenthal DI; Beadle BM; Frank SJ; Fuller CD; Gunn GB; Morrison WH; Hutcheson K; El-Naggar AK; Gold KA; Kupferman ME; Phan J
Head Neck; 2016 Apr; 38 Suppl 1():E925-33. PubMed ID: 25994561
[TBL] [Abstract][Full Text] [Related]
14. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
15. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.
McDonald MW; Liu Y; Moore MG; Johnstone PA
Radiat Oncol; 2016 Feb; 11():32. PubMed ID: 26922239
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of robustly optimised intensity modulated proton therapy for nasopharyngeal carcinoma.
Scandurra D; Meijer TWH; Free J; van den Hoek JGM; Kelder L; Oldehinkel E; Steenbakkers RJHM; Both S; Langendijk JA
Radiother Oncol; 2022 Mar; 168():221-228. PubMed ID: 35134448
[TBL] [Abstract][Full Text] [Related]
17. Potential benefits of adaptive intensity-modulated proton therapy in nasopharyngeal carcinomas.
Minatogawa H; Yasuda K; Dekura Y; Takao S; Matsuura T; Yoshimura T; Suzuki R; Yokota I; Fujima N; Onimaru R; Shimizu S; Aoyama H; Shirato H
J Appl Clin Med Phys; 2021 Jan; 22(1):174-183. PubMed ID: 33338323
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma.
Lee TF; Fang FM; Chao PJ; Su TJ; Wang LK; Leung SW
Radiother Oncol; 2008 Oct; 89(1):89-96. PubMed ID: 18524401
[TBL] [Abstract][Full Text] [Related]
19. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.
Huang H; Lu H; Feng G; Jiang H; Chen J; Cheng J; Pang Q; Lu Z; Gu J; Peng L; Deng S; Mo Y; Wu D; Wei Y
Radiat Oncol; 2015 Sep; 10():192. PubMed ID: 26377685
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma.
Lin L; Yao JJ; Zhou GQ; Guo R; Zhang F; Zhang Y; Xu L; Zhang LL; Lin AH; Ma J; Sun Y
Oncotarget; 2016 Apr; 7(15):20680-90. PubMed ID: 26980744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
